VL
Insider
Versant Vantage II GP-GP, LLC
10% ownerVersant Vantage II GP-GP, LLC (10% owner) filed 3 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 3 sales), most often in LENZ Therapeutics, Inc. (LENZ). The largest single filing was $10.2M of LENZ (350,000 sh × $29.00, as filed), executed Jun 10 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$16.2M
shares × price, as filed
Last traded
Sep 30 2025
Filed Oct 2 2025
Median ADV $2.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $16.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
LENZ
LENZ Therapeutics, Inc.
LENZ · 0 buys · 3 sells
3 filings
Recent filings
LENZSALE
LENZ Therapeutics, Inc.
View filing →
–224,674 sh across 4 lots · price not plausible
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET LENZSALE LENZ Therapeutics, Inc. View filing → $6.1M
200,000 sh × $30.47
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET LENZSALE LENZ Therapeutics, Inc. View filing → $10.2M
350,000 sh × $29.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET